GB-102

sunitinib malate depot formulation · Graybug Vision

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GB-102, covering 2021-07-15 to 2021-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion [Phase 2]

See pricing